{"schema_version":"secwatch.filing_event.v1","accession":"0001799191-23-000044","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2023-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.284818+00:00","generated_at":"2026-06-10T23:32:43.885986+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"The Oncology Institute appoints Jeremy Castle as COO with $375K base salary","bullets":["Jeremy N. Castle appointed COO effective September 5, 2023, replacing Matthew Miller, MD who departed June 16, 2023.","Castle previously served as VP of Operations at OneOncology (Jan 2022-Aug 2023); over 15 years in healthcare operations.","Base salary $375,000; target annual bonus 40% of base; $50,000 signing/relocation bonus.","Employment agreement has three-year initial term; severance of three months salary/COBRA if terminated without cause or for good reason.","No family relationships with directors/officers; no related party transactions required to be disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001799191-23-000044","json":"https://secwatch.observer/filing/0001799191-23-000044.json","markdown":"https://secwatch.observer/filing/0001799191-23-000044.md","text":"https://secwatch.observer/filing/0001799191-23-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/0001799191-23-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/toi-20230906.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:32:43.885986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16ef257d54","claim":"Jeremy N. Castle was appointed as Chief Operations Officer at Oncology Institute, Inc..","evidence_excerpt":"On September 5, 2023, The Oncology Institute, Inc., a Delaware corporation (the “Company”), appointed Jeremy N. Castle to replace Matthew Miller, MD as the Company’s Chief Operations Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/0001799191-23-000044-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operations Officer"}],"fact_type":"executive_change"},{"claim_id":"e003e19af3","claim":"Matthew Miller, MD departed as Chief Operations Officer at Oncology Institute, Inc..","evidence_excerpt":"Dr. Miller’s separation from the Company was effective June 16, 2023, as previously disclosed in that certain Current Report on Form 8-K filed with the Securities and Exchange Commission on May 22, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919123000044/0001799191-23-000044-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Operations Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}